About Biocon Limited (BIOCON)
Biocon Limited is a Biotechnology company operating in the Healthcare sector. The company is headquartered in Bengaluru, India. BIOCON has been publicly traded since 2004, giving it 22+ years of trading history.
Biocon Limited (BIOCON) has been publicly traded since 2004, making it a 22-year-old public company. It operates in the Biotechnology industry within the Healthcare sector. The company is headquartered in Bengaluru, India. With a market capitalization of $621 billion, BIOCON is one of the largest publicly traded companies.
BIOCON trades on the Indian stock exchanges (NSE/BSE) and is classified as a mega-cap-cap stock with a market capitalization of approximately $621 billion.
Key Statistics
- Current Price
- ₹383.55
- Market Cap
- ₹621.09B
- 52-Week High
- ₹424.95
- 52-Week Low
- ₹299.00
- Sector
- Healthcare
- Industry
- Biotechnology
BIOCON Investment Performance
BIOCON has declined 2.6% year-to-date in 2026. Over the past 5 years, a $1,000 investment in BIOCON would have grown to $957, representing a -4.3% total return. Since its IPO in 2004, a $1,000 investment would now be worth $11,206.
₹1,000 Invested in Biocon Limited (BIOCON)
How much would ₹1,000 invested in BIOCON be worth today?
What would ₹1,000 invested in BIOCON 1 year ago be worth today?
A ₹1,000 investment in Biocon Limited (BIOCON) in 2025 would be worth ₹1,151 as of May 2026, representing a +15.1% total return.
What would ₹1,000 invested in BIOCON 3 years ago be worth today?
A ₹1,000 investment in Biocon Limited (BIOCON) in 2023 would be worth ₹1,699 as of May 2026, representing a +69.9% total return.
What would ₹1,000 invested in BIOCON 5 years ago be worth today?
A ₹1,000 investment in Biocon Limited (BIOCON) in 2021 would be worth ₹957 as of May 2026, representing a -4.3% total return.
What would ₹1,000 invested in BIOCON 10 years ago be worth today?
A ₹1,000 investment in Biocon Limited (BIOCON) in 2016 would be worth ₹4,535 as of May 2026, representing a +353.5% total return.
What would ₹1,000 invested in BIOCON at IPO be worth today?
A ₹1,000 investment in Biocon Limited (BIOCON) at IPO would be worth ₹11,206 as of May 2026, representing a +1020.6% total return.
Monthly Returns Heatmap
Over the past 21+ years (263 months), Biocon Limited (BIOCON) has averaged a monthly return of +1.33% with a median return of +0.75%. The stock had 145 positive months (55%) and 118 negative months (45%). The best month in BIOCON's history was March 2009 with a +40.7% return, while the worst was October 2008 at -46.8%. Historically, April tends to be the strongest month (averaging +6.1%), and January the weakest (-4.5%).
BIOCON's longest winning streak was 7 consecutive months of gains, while its longest losing streak was 6 consecutive months of losses. The best full year was 2009 with a cumulative return of +101.6%, and the worst was 2008 at -55.8%.
Annual Returns
Over 22 years of trading history, Biocon Limited (BIOCON) has delivered an average annual return of +20.07% with a median return of +7.44%. The compound annual growth rate (CAGR) is +11.35%. The stock posted gains in 12 years (55%) and losses in 10 years (45%).
BIOCON's best year was 2009 with a +140.10% gain, while the worst was 2008 at -59.09%. The longest streak of consecutive positive years was 4, and the longest losing streak was 3 years. BIOCON achieved double-digit gains (10%+) in 10 years. It suffered double-digit losses in 5 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | -2.63% | ₹393.90 | ₹383.55 |
| 2025 | +7.96% | ₹364.86 | ₹393.90 |
| 2024 | +46.55% | ₹248.97 | ₹364.86 |
| 2023 | -4.10% | ₹259.63 | ₹248.97 |
| 2022 | -28.08% | ₹360.97 | ₹259.63 |
| 2021 | -21.65% | ₹460.71 | ₹360.97 |
| 2020 | +58.46% | ₹290.74 | ₹460.71 |
| 2019 | -6.44% | ₹310.76 | ₹290.74 |
| 2018 | +17.28% | ₹264.98 | ₹310.76 |
| 2017 | +70.11% | ₹155.77 | ₹264.98 |
| 2016 | +85.29% | ₹84.07 | ₹155.77 |
| 2015 | +23.02% | ₹68.34 | ₹84.07 |
| 2014 | -7.11% | ₹73.57 | ₹68.34 |
| 2013 | +65.59% | ₹44.43 | ₹73.57 |
| 2012 | +6.92% | ₹41.55 | ₹44.43 |
| 2011 | -34.12% | ₹63.08 | ₹41.55 |
| 2010 | +54.15% | ₹40.92 | ₹63.08 |
| 2009 | +140.10% | ₹17.04 | ₹40.92 |
| 2008 | -59.09% | ₹41.65 | ₹17.04 |
| 2007 | +55.49% | ₹26.79 | ₹41.65 |
| 2006 | -24.00% | ₹35.25 | ₹26.79 |
| 2005 | -2.26% | ₹36.06 | ₹35.25 |
BIOCON Investment Analysis: Valuation, Risk & Dividends
Key factors to consider when evaluating Biocon Limited as an investment
Valuation
BIOCON currently trades at a trailing P/E ratio of 78.8, which is considered high relative to the broader market. The forward P/E of 41.6 suggests analysts expect earnings to be lower in the coming year. The price-to-book ratio stands at 1.8. The price-to-sales ratio is 3.7.
Dividends
Biocon Limited pays a dividend to shareholders with a current yield of 0.13%. This translates to $0.50 per share annually. The payout ratio of 10% indicates sustainable dividend coverage.
Risk & Volatility
BIOCON has a beta of 0.21, indicating it is less volatile than the overall market. The stock's 52-week range is $299.00 to $424.95, and it currently trades in the upper half of its 52-week range.
Analyst Ratings
Based on 19 analyst opinions, BIOCON has a consensus "buy" rating. The average price target of $422.84 suggests 10.2% upside from current levels.
Frequently Asked Questions: BIOCON
What sector is BIOCON in? ▼
BIOCON operates in the Healthcare sector, specifically in the Biotechnology industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has BIOCON performed historically? ▼
Over 22 years of trading history, BIOCON has posted gains in 12 years (55% of the time). The best year was 2009 with a +140.1% return. Past performance does not guarantee future results.
How can I invest in BIOCON? ▼
You can invest in BIOCON through any brokerage account that offers access to Indian exchanges. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold BIOCON.
Does BIOCON pay dividends? ▼
Biocon Limited pays a dividend to shareholders with a current yield of 0.13%. This translates to $0.50 per share annually. The payout ratio of 10% indicates sustainable dividend coverage.
What does Biocon Limited do? ▼
Biocon Limited is a Biotechnology company operating in the Healthcare sector. The company is headquartered in Bengaluru, India.
What sector is BIOCON in? ▼
BIOCON operates in the Healthcare sector, specifically in the Biotechnology industry.
When did BIOCON go public? ▼
Biocon Limited went public in 2004, making it a 22-year-old public company as of 2026.
How much would $1,000 invested in BIOCON 5 years ago be worth today? ▼
A $1,000 investment in BIOCON five years ago would be worth approximately $957 today, representing a -4.3% return.
Does BIOCON pay dividends? ▼
Yes, Biocon Limited pays a dividend with a current yield of 0.13%, which is $0.5 per share annually.
What is BIOCON's market cap? ▼
Biocon Limited has a market capitalization of $621 billion, classifying it as a mega-cap company.
What is BIOCON's P/E ratio? ▼
BIOCON has a trailing P/E ratio of 78.8 and a forward P/E of 41.6, which measures how much investors are paying per dollar of earnings.
Is BIOCON a buy, hold, or sell? ▼
Based on 19 opinions, BIOCON has a consensus "buy" rating. The average price target is $422.84.
Last updated: 3/14/2026